Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...
Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...
Aurora Cannabis CEO Miguel Martin thinks the cannabis industry and its investors are too focused on US recreational consumers and are missing a more profitable opportunity: medical marijuana.
CreditRiskMonitor told Insider that most mature industries average a score of 6, which is slightly under a 1% probability of ... Aphria: 6 Aurora Cannabis: 6 Canopy Growth: 6 Hexo Corp: 6 Harvest ...
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results